Clinical Trial Update: Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study [NA]

View source ↗

Summary

A pilot clinical trial aims to identify volatile biomarkers in skin odor that differentiate malignant melanoma, basal cell carcinoma, and squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Malignant Melanoma
• Squamous Cell Carcinoma

Snippet

Sponsor: Association pour la Recherche Clinique et Immunologique | Conditions: Identify Volatile Biomarkers Specific to Malignant Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma, Verify That the Volatile Biomarkers Identified Derive From Metabolic Changes in Body Odour and Not Just From Changes in the Surface of Cancerous Lesions | NA | Status: NOT_YET_RECRUITING